Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study - Concepedia

Concepedia

Publication | Closed Access

Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study

105

Citations

27

References

2013

Year

Gitte Sørensen, Steve W. Cole, Lars Pedersen, Henrik Toft Sørensen, Deirdre Cronin‐Fenton, Jens Peter Garne, Peer Christiansen, Timothy L. Lash, Thomas P. Ahern

Journal of Clinical Oncology

Abstract

Our data do not support the hypothesis that β-blockers attenuate breast cancer recurrence risk.

References

	Year	Citations

Page 1